emeafinance Magazine
[ Skip to content ]
[ Skip to navigation ]
  • Small sum, big deal

Small sum, big deal

Small sum, big deal

It’s a company you may never have heard of, but Russia’s Human Stem Cell Institute wants to reopen the country’s IPO market and become a global biotech player. Founder Artur Isaev tells Tim Burke how he plans to do it.

Last Edited: December 17, 2009 | Send to Friend

Restricted Access

To read the full version of this article you must be subscribed to emeafinance.

Subscriber Log In

If you are already subscribed, please log in here:

Forgotten your password?

Subscribe Online

If you are not a subscriber, you can sign up for an annual subscription or a 7 day free trial.

 
*
*
*
*
 

Thank you, your message has been sent.

Close

emeafinance Subscriptions

Subscribe online now for emeafinance

emeafinance awards logo
emeafinance recognises the best banks in Africa. Closing deadline for submissions: 3 September 2010
GTR

Take a look at our other publications including Global Trade Review

Singapore

Singapore - October 5-6, 2010

2nd Annual Asia Trade & Export Finance Conference

United Kingdom

London - November 3-4, 2010

2nd Annual West Africa Trade & Commodity Finance Conference

Egypt

Cairo - November 10-11, 2010

3rd Annual North Africa Trade & Investment Conference

Sweden

Gothenburg - November 18, 2010

3rd Annual Nordic Region Trade & Export Finance Forum

United Arab Emirates

Dubai - February 15-16, 2011

8th Annual Middle East Trade & Export Finance Conference

 
#2 #3 #4 #5 #6 #7 #8 #9 #10 #11 #12 #13 #14 #15 #16 #17 #18 #19 #20